Ajax Health Raises an Additional $15 million, for a Total of More Than $100 million, to Close Out Ajax II
Ajax Health announced today that it has raised an additional $15 million, closing out Ajax II at a total of more than $100 million. This is in addition to the $85 million previously announced in April 2019. A portion of the capital has already been deployed for investments in Ablacon Inc. and Cortica Inc. The remainder of the money raised will be used to strategically operate and expand additional, innovative medical device companies. HealthQuest Capital led the funding, with participation from Aisling Capital and Polaris Partners.